Hemorrhagic Complications in Acute Ischemic Stroke

Created 26/04/2021, last revision 03/09/2023

  • the efficacy of intravenous thrombolysis has been demonstrated despite an increased risk of bleeding in patients treated with tPA
  • knowledge of risk factors for significant bleeding may improve patient selection and treatment safety; interpretation of trial results is difficult because different classifications of hemorrhagic transformation have been used
    • CT-based classification does not provide direct information on the clinical consequences of hemorrhage
    • clinical classification does not acknowledge the contribution of ischemic edema to clinical deterioration
    • the use of both clinical and radiologic criteria seems optimal

ECASS group hemorrhage classification

Radiologic hemorrhage classification (Larrue, 2001)
Hemorrhagic infarction (HI) – petechiae in the infarcted tissue without space-occupying effect
HI1 small isolated petechiae along the margins of the infarct
HI2 confluent petechiae
Parenchymal hemorrhage (PH) – hemorrhage with space-occupying effect
PH1 blood clots in ≤ 30% of the infarct area with a slight space-occupying effect
PH2 blood clots in > 30% of the infarct area with a substantial space-occupying effect
Hemorrhage classification after stroke/reperfusion (ECASS II)
Bleeding classification after Stroke and Reperfusion Therapy (ECASS II)

Definitions of symptomatic hemorrhage (sICH)

Definition of a symptomatic intracranial hemorrhage (SICH) in different trials
  • an intracranial hemorrhage was defined as symptomatic (SICH) if the patient had clinical deterioration (increase in  NIHSS score ≥4 points) and if the hemorrhage was likely to have caused the clinical deterioration
  • in case of doubt, a relationship between the hemorrhage and the deterioration was assumed
 any hemorrhage + any clinical deterioration
local or remote parenchymal hemorrhage type 2 (PH2) + clinical deterioration  (NIHSS increase ≥ 4  or death) within 24 hours
new intracranial hemorrhage detected by CT/MRI associated with any of the following:

  • ≥4 points in total NIHSS compared to immediately before deterioration (not baseline)
  • ≥2 points in any NIHSS category (to capture new bleeding that causes new symptoms)
  • leading to intubation/hemicraniectomy/EVD placement or other major medical/surgical intervention
  • + absence of an alternative explanation for the deterioration

The Heidelberg Bleeding Classification

1 Hemorrhagic transformation of infarcted brain tissue
1a Scattered small petechiae, no mass effect (HI1)
1b Confluent petechiae, no mass effect (HI2)
1c Hematoma within infarcted tissue, occupying <30%, no substantive mass effect  (PH1)
2 Intracerebral hemorrhage within and beyond infarcted brain tissue
Hematoma occupying 30% or more of the infarcted tissue, with obvious mass effect  (PH2)
3 Intracerebral hemorrhage outside the infarcted brain tissue or intracranial-extracerebral hemorrhage
3a Parenchymal hematoma remote from infarcted brain tissue
3b Intraventricular hemorrhage
3c Subarachnoid hemorrhage
3d Subdural hemorrhage

You cannot copy content of this page

Send this to a friend
you may find this topic useful:

Hemorrhagic Complications in Acute Ischemic Stroke